HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jacek S Małyszko Selected Research

Acute Coronary Syndrome

5/2005Markers of endothelial cell activation/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jacek S Małyszko Research Topics

Disease

7Chronic Kidney Failure (Chronic Renal Failure)
01/2007 - 09/2002
4Cardiovascular Diseases (Cardiovascular Disease)
12/2009 - 01/2002
2Dyslipidemias (Dyslipidemia)
12/2009 - 06/2002
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2006 - 05/2005
2Kidney Diseases (Kidney Disease)
11/2005 - 06/2002
2Anemia
11/2005 - 01/2002
2Nephrotic Syndrome (Syndrome, Nephrotic)
01/2005 - 01/2004
2Diabetic Nephropathies (Diabetic Nephropathy)
03/2004 - 08/2003
2Atherosclerosis
03/2004 - 01/2004
2Thrombosis (Thrombus)
01/2004 - 01/2002
2Renal Insufficiency (Renal Failure)
01/2004 - 09/2002
1Hypercalcemia (Milk Alkali Syndrome)
12/2017
1Secondary Hyperparathyroidism
12/2017
1Bone Resorption
01/2007
1Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
01/2007
1Cardiomyopathies (Cardiomyopathy)
01/2006
1Iron Deficiencies
11/2005
1Hypoxia (Hypoxemia)
11/2005
1Inflammation (Inflammations)
11/2005
1Diabetes Mellitus
05/2005
1Obesity
05/2005
1Acute Coronary Syndrome
05/2005
1Hypertension (High Blood Pressure)
09/2002
1Vitamin K Deficiency
09/2002
1Bone Diseases (Bone Disease)
09/2002

Drug/Important Bio-Agent (IBA)

3ErythropoietinFDA Link
11/2005 - 01/2002
3Hemostatics (Antihemorrhagics)IBA
01/2005 - 01/2002
2Fibrinogen (Factor I)FDA Link
12/2009 - 03/2004
2OsteocalcinIBA
01/2007 - 09/2002
2ThrombinFDA Link
03/2004 - 08/2003
1paricalcitol (Zemplar)FDA Link
12/2017
1Cinacalcet (Sensipar)FDA Link
12/2017
1CalciumIBA
12/2017
1Protein Isoforms (Isoforms)IBA
01/2007
1Alkaline PhosphataseIBA
01/2007
1procollagen type I carboxy terminal peptide (PICP)IBA
01/2007
1ApelinIBA
01/2006
1HepcidinsIBA
11/2005
1IronIBA
11/2005
1AdiponectinIBA
05/2005
1Proteins (Proteins, Gene)FDA Link
01/2005
1LeptinIBA
06/2004
1AlbuminsIBA
03/2004
1Antifibrinolytic Agents (Antifibrinolytics)IBA
03/2004
1Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
03/2004
1AntithrombinsIBA
03/2004
1FibrinolysinFDA Link
03/2004
1Triglycerides (Triacylglycerol)IBA
03/2004
1Prothrombin (Factor II)IBA
03/2004
1ThrombomodulinIBA
01/2004
1E-SelectinIBA
01/2004
1von Willebrand FactorIBA
01/2004
1FibrinIBA
01/2004
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
01/2004
1P-SelectinIBA
01/2004
1Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2002
1Vitamin KFDA Link
09/2002
1Biomarkers (Surrogate Marker)IBA
09/2002
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2002
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2002
1LipidsIBA
06/2002
1Oxidoreductases (Dehydrogenase)IBA
06/2002
1HomocysteineIBA
01/2002

Therapy/Procedure

5Continuous Ambulatory Peritoneal Dialysis (CAPD)
01/2005 - 06/2002
3Renal Dialysis (Hemodialysis)
12/2017 - 03/2004
3Renal Replacement Therapy (Therapies, Renal Replacement)
12/2009 - 03/2006
3Peritoneal Dialysis
01/2005 - 01/2004
3Conservative Treatment
03/2004 - 09/2002
1Hemodiafiltration
03/2006
1Therapeutics
11/2005
1Organ Transplantation
09/2002